Corpus Engine Towards a reproducible .science file.
← All .science files

pmid:39751894

The correlation between LAG-3 expression and the efficacy of chemoimmunotherapy in advanced biliary tract cancer.

Cancer immunology, immunotherapy : CII · 2025 doi:10.1007/s00262-024-03878-0

Paper

partial

Experiment

partial

Data

partial

Analysis

absent

Execution

absent

Execution evidence has not yet been added to this .science file. Explore its methods, data and open questions to plan the next step.
Record details sci_version · id · kind · revision · content_hash · schema · created_at · updated_at · generator
id
pmid:39751894
kind
science-record
content_hash
sha256:3f4ec524d9d46a571f9ab71ab55a859d9b58b23f6c9759ec51aa132e025eace9
schema
https://corpus.bntrg.co.uk/sci/1.0/sci.schema.json
created_at
2026-11-01T10:25:48Z
updated_at
2026-11-01T14:01:32Z
generator object · 3 fields
name
corpus-assay-engine
converter
sep_to_sci_v1
source_package_schema
urn:bntrg:sep:1.0.0
paper object · 10 fields
state
partial
title
The correlation between LAG-3 expression and the efficacy of chemoimmunotherapy in advanced biliary tract cancer.
doi
10.1007/s00262-024-03878-0
pmid
39751894
authors
null
journal
Cancer immunology, immunotherapy : CII
year
2025
abstract
null
claims array · 1 item
[0] object · 6 fields
id
claim-1
statement
the headline numerical result the paper states for its main finding
kind
quantitative
state
complete
target object · 4 fields
value
70.6
unit
percent
tolerance
null
source
chars 1132-1275 of source sha256 c2cc7c034d43a161cbee6bf48b1df2ed9484287c0028b97b855f75c3c6d71774
evidence array · 1 item
[0] object · 3 fields
asset
source:pmid:39751894
locator
chars 1132-1275 of source sha256 c2cc7c034d43a161cbee6bf48b1df2ed9484287c0028b97b855f75c3c6d71774
quote
The objective response rate (ORR) was significantly higher in LAG-3-positive tumors than in LAG-3-negative tumors (70.6% vs. 33.3%, P = 0.029).
gaps array · 2 items
[0]
abstract
[1]
authors
experiment object · 8 fields
state
partial
objective
the headline numerical result the paper states for its main finding
steps array · 3 items
[0] object · 13 fields
id
read_published_estimate
order
1
name
Read the published estimate and its interval from the source
kind
other
state
complete
blocked_on
null
description
The number a replication must land on, and the sentence it came from.
parameters object · 0 fields
inputs array · 1 item
[0]
source:pmid:39751894
outputs array · 1 item
[0]
the published estimate, its unit and its interval
instruments array · 0 items
reagents array · 0 items
[1] object · 13 fields
id
obtain_source_data
order
2
name
Obtain the source data behind the published result
kind
data-preparation
state
blocked
blocked_on
data:not_downloaded
description
The published result cannot be recomputed without the data the paper analysed.
parameters object · 0 fields
inputs array · 0 items
outputs array · 1 item
[0]
the source data with its provenance
instruments array · 0 items
reagents array · 0 items
[2] object · 13 fields
id
run_analysis
order
3
name
Run the analysis programme
kind
analysis
state
blocked
blocked_on
no owned computational capability is bound to this experiment
description
Re-run the paper's analysis on the source data and produce the registered result. | SEP input not carried into the asset list: materials:the source data behind the published result in pmid:39751894
parameters object · 0 fields
inputs array · 0 items
outputs array · 1 item
[0]
the registered result
instruments array · 0 items
reagents array · 0 items
materials array · 0 items
instruments array · 0 items
reagents array · 0 items
conditions object · 0 fields
gaps array · 3 items
[0]
step:obtain_source_data blocked on data:not_downloaded
[1]
step:run_analysis blocked on no owned computational capability is bound to this experiment
[2]
step:run_analysis input 'materials:the source data behind the published result in pmid:39751894' does not resolve to a declared asset
data object · 3 fields
state
partial
assets array · 3 items
[0] object · 15 fields
id
source:pmid:39751894
role
manuscript
format
xml
media_type
application/xml
uri
https://doi.org/10.1007/s00262-024-03878-0
sha256
sha256:c2cc7c034d43a161cbee6bf48b1df2ed9484287c0028b97b855f75c3c6d71774
bytes
null
access
open
state
resolved
reader
null
reader_status
reader_required
identifier
10.1007/s00262-024-03878-0
version
null
note
Source read by the package builder: full_text.
structure object · 1 field
access_state
full_text
[1] object · 16 fields
id
asset:table:pmid:39751894:1
role
table
format
jats-table
media_type
application/vnd.jats.table+json
uri
null
sha256
sha256:effbc6714246de9e2ed13d14ecf64d0e237c36acd6b6b2eb601827dd9cb20893
bytes
1043
access
open
state
verified
reader
read_table
reader_status
available
identifier
section[10]/table-wrap[1]#Tab1
version
null
note
Demographic difference between LAG-3-positive and LAG-3-negative subgroup
structure object · 5 fields
pmcid
PMC11699023
section_index
10
section_title
Patient characteristics
row_count
20
column_count
5
table object · 8 fields
label
Table 1
caption
Demographic difference between LAG-3-positive and LAG-3-negative subgroup
rows array · 20 items
[0] array · 5 items
[0]
Characteristic
[1]
All (N = 44)
[2]
LAG-3-positive (N = 17)
[3]
LAG-3-negative (N = 27)
[4]
P value
[1] array · 1 item
[0]
Age
[2] array · 5 items
[0]
Median (range), year
[1]
67 (30–80)
[2]
67 (30–80)
[3]
68(35–80)
[4]
0.407
[3] array · 1 item
[0]
Sex (%)
[4] array · 5 items
[0]
Male
[1]
20 (45)
[2]
8 (47)
[3]
12 (44)
[4]
> 0.99
[5] array · 4 items
[0]
Female
[1]
24 (55)
[2]
9 (53)
[3]
15 (56)
[6] array · 1 item
[0]
Stage (%)
[7] array · 5 items
[0]
II
[1]
1 (2)
[2]
0 (0)
[3]
1 (4)
[4]
NA
[8] array · 4 items
[0]
III
[1]
2 (5)
[2]
0 (0)
[3]
2 (7)
[9] array · 4 items
[0]
IIIB
[1]
4 (9)
[2]
2 (12)
[3]
2 (7)
[10] array · 4 items
[0]
IVA
[1]
7 (16)
[2]
3 (18)
[3]
4 (15)
[11] array · 4 items
[0]
IVB
[1]
30 (68)
[2]
12 (70)
[3]
18 (67)
[12] array · 1 item
[0]
Primary tumor site (%)
[13] array · 5 items
[0]
Intrahepatic bile duct
[1]
26 (59)
[2]
9 (53)
[3]
17 (63)
[4]
NA
[14] array · 4 items
[0]
Extrahepatic bile duct
[1]
11 (25)
[2]
5 (29)
[3]
6 (22)
[15] array · 4 items
[0]
Gallbladder
[1]
5 (11)
[2]
1 (6)
[3]
4 (15)
[16] array · 4 items
[0]
Ampulla of vater
[1]
2 (5)
[2]
2 (12)
[3]
0 (0)
[17] array · 1 item
[0]
PD-L1 expression (%)
[18] array · 5 items
[0]
CPS ≥ 1
[1]
18 (41)
[2]
14 (82)
[3]
4 (15)
[4]
< 0.001
[19] array · 4 items
[0]
CPS < 1
[1]
26 (59)
[2]
3 (18)
[3]
23 (85)
locator
section[10]/table-wrap[1]#Tab1
[2] object · 16 fields
id
asset:table:pmid:39751894:2
role
table
format
jats-table
media_type
application/vnd.jats.table+json
uri
null
sha256
sha256:fb8d2de8e853ca70f330eff0ba3e6f3aa90c0bef0fecf58f1108458d72f61791
bytes
492
access
open
state
verified
reader
read_table
reader_status
available
identifier
section[10]/table-wrap[2]#Tab2
version
null
note
Response rate in this study
structure object · 5 fields
pmcid
PMC11699023
section_index
10
section_title
Patient characteristics
row_count
9
column_count
2
table object · 8 fields
label
Table 2
caption
Response rate in this study
rows array · 9 items
[0] array · 2 items
[0]
Best overall response
[1]
N = 44 (%)
[1] array · 2 items
[0]
Complete response
[1]
0 (0)
[2] array · 2 items
[0]
Partial response
[1]
21 (47.7)
[3] array · 2 items
[0]
Stable disease
[1]
4 (9.1)
[4] array · 2 items
[0]
Stable disease ≥ 12 weeks
[1]
13 (29.5)
[5] array · 2 items
[0]
Progressive disease
[1]
5 (11.4)
[6] array · 2 items
[0]
Not evaluated
[1]
1 (2.3)
[7] array · 2 items
[0]
Objective response
[1]
21 (47.4)
[8] array · 2 items
[0]
Long-term disease control
[1]
34 (77.3)
locator
section[10]/table-wrap[2]#Tab2
gaps array · 1 item
[0]
asset:source:pmid:39751894 not verified
analysis object · 4 fields
state
absent
methods array · 0 items
targets array · 0 items
gaps array · 2 items
[0]
method
[1]
targets
capability object · 3 fields
state
absent
requirements array · 0 items
gaps array · 1 item
[0]
capability
readiness object · 8 fields
state
partial
tier
null
blocked_on
null
axes object · 0 fields
can_run object · 3 fields
dsl_operations array · 0 items
assets array · 3 items
[0]
source:pmid:39751894
[1]
asset:table:pmid:39751894:1
[2]
asset:table:pmid:39751894:2
steps array · 1 item
[0]
read_published_estimate
must_build object · 5 fields
dsl_operations array · 0 items
converters array · 0 items
readers array · 1 item
[0]
xml
capabilities array · 0 items
data_gaps array · 1 item
[0]
source:pmid:39751894
gaps array · 1 item
[0]
corpus_record_absent
review object · 5 fields
state
partial
machine_critique object · 7 fields
status
blocked
providers array · 2 items
[0] object · 7 fields
provider
minimax
model
MiniMax-M3.1-Flash
prompt_version
full-text-reading-v1
prompt_hash
637d93870f423ad621f21057f8469d3ac69911136bc30089459152336b7c4520
source_hash
c2cc7c034d43a161cbee6bf48b1df2ed9484287c0028b97b855f75c3c6d71774
raw_response_sha256
sha256:2cb5d11e2729bb16dcac93ba5ac55da949c184fbf4bd17f681df4cab54cc776c
raw_response_chars
2471
[1] object · 7 fields
provider
minimax_alt
model
MiniMax-M3
prompt_version
full-text-reading-v1
prompt_hash
3eeb2a7da4363c87b0de6dbea1909601a20252d9a4cd48dbe9f84e8c3564a799
source_hash
c2cc7c034d43a161cbee6bf48b1df2ed9484287c0028b97b855f75c3c6d71774
raw_response_sha256
sha256:12979860c58f21e78c7bfb6487cb9c4d74a5d96fc0371c99a2ad7a0e12398f46
raw_response_chars
34464
target_providers array · 2 items
[0] object · 8 fields
provider
minimax
model
MiniMax-M3.1-Flash
prompt_version
replication-target-v2
prompt_hash
a54f7c24df0f409c0799bd6d6b9d26c6e69e94c2c0bf387788ab7f6cac589f94
source_hash
c2cc7c034d43a161cbee6bf48b1df2ed9484287c0028b97b855f75c3c6d71774
raw_response
{"parent_value":70.6,"unit":"%","evidence":"The objective response rate (ORR) was significantly higher in LAG-3-positive tumors than in LAG-3-negative tumors (70.6% vs. 33.3%, P = 0.029).","target_result":"The objective response rate was 70.6% in LAG-3-positive tumors, compared with 33.3% in LAG-3-negative tumors.","number_stated":true}
reading object · 6 fields
parent_value
70.6
unit
%
evidence
The objective response rate (ORR) was significantly higher in LAG-3-positive tumors than in LAG-3-negative tumors (70.6% vs. 33.3%, P = 0.029).
target_result
The objective response rate was 70.6% in LAG-3-positive tumors, compared with 33.3% in LAG-3-negative tumors.
number_stated
true
source_locator
chars 1132-1275 of source sha256 c2cc7c034d43a161cbee6bf48b1df2ed9484287c0028b97b855f75c3c6d71774
recorded_at
2026-10-31T15:26:22.006161+00:00
[1] object · 8 fields
provider
minimax_alt
model
MiniMax-M3
prompt_version
replication-target-v2
prompt_hash
ff02a4c17d4788b9600fbae36de818f0a8154a1312c26fbecb23b8334cb09519
source_hash
c2cc7c034d43a161cbee6bf48b1df2ed9484287c0028b97b855f75c3c6d71774
raw_response
<think>We need answer JSON only. Need interpret request: single numerical result replication registered target main finding. Need headline number only, paper stated, unit printed. Target broad "headline numerical result paper states for main finding". Need determine likely main headline number from abstract. Could be ORR 70.6% vs 33.3%, P=.029. "headline numerical result" likely 70.6%? Main finding LAG-3 positivity predicts efficacy, objective response rate. Need exact contiguous quotation contains number, whole clause for attribution. Need parent_value number likely 70.6, unit "%". Evidence exact sentence: "The objective response rate (ORR) was significantly higher in LAG-3-positive tumors than in LAG-3-negative tumors (70.6% vs. 33.3%, P = 0.029)." That contains both. But asks "single numerical result" headline number only, value paper states for registered target. They expect one number. Could headline result be 38.6% LAG-3 positivity? Yet main finding as efficacy likely ORR 70.6 vs 33.3. Registered target intentionally generic. Need output one number and unit. Evidence must quote whole clause. target_result likely "70.6%" maybe. number_stated true. parent_value 70.6. Need ensure exact quotation and no shortening. "The objective response rate (ORR) was significantly higher..." Whole clause/sentence. Evidence contains multiple numerical values, but headline number only in parent_value. Is that okay? They insist evidence exact contiguous quote contains number. likely. Could potentially headline numerical result be deeper therapeutic response, 20.1%, 38.6%, 57.6%. But main headline abstract results usually first ORR. Let's parse wording: "find the single numerical result that a replication of the registered target has to reproduce. REGISTERED TARGET: the headline numerical result the paper states for its main finding." This likely benchmark where target description vague and extract headline. Main finding could be "LAG-3 expression may serve as biomarker", headline numerical result ORR significantly higher: 70.6% vs 33.3%. Single result perhaps 70.6% (the positive group's ORR), comparison 33.3. Need perhaps evidence entire clause "The objective response rate (ORR) was significantly higher in LAG-3-positive tumors than in LAG-3-negative tumors (70.6% vs. 33.3%, P = 0.029)." Good. Could unit be "%" exactly printed. parent_value 70.6. target_result maybe "The objective response rate was 70.6% in LAG-3-positive tumors." But should only headline number? They request target_result perhaps state result. We can put "70.6%" only. Need valid JSON escaping? Evidence exact Unicode en dash etc not issue. We must not invent source. Use exact source. Ensure exact quotation punctuation. Sentence from source exactly. Let's deliver JSON.</think> {"parent_value":70.6,"unit":"%","evidence":"The objective response rate (ORR) was significantly higher in LAG-3-positive tumors than in LAG-3-negative tumors (70.6% vs. 33.3%, P = 0.029).","target_result":"70.6%","number_stated":true}
reading object · 6 fields
parent_value
70.6
unit
%
evidence
The objective response rate (ORR) was significantly higher in LAG-3-positive tumors than in LAG-3-negative tumors (70.6% vs. 33.3%, P = 0.029).
target_result
70.6%
number_stated
true
source_locator
chars 1132-1275 of source sha256 c2cc7c034d43a161cbee6bf48b1df2ed9484287c0028b97b855f75c3c6d71774
recorded_at
2026-10-31T15:26:24.676693+00:00
agreement
false
disagreements object · 2 fields
work_type object · 3 fields
minimax
analysis_only_for_target
minimax_alt
analysis_plus_physical_validation
decisive
true
physical_methods object · 3 fields
minimax array · 0 items
minimax_alt array · 2 items
[0]
Immunohistochemical staining for PD-L1 and LAG-3
[1]
Digital spatial profiling in selected regions of interest
decisive
false
agreement_basis object · 2 fields
policy
decisive_fields
decisive_fields array · 4 items
[0]
work_type
[1]
number_stated
[2]
parent_value
[3]
unit
blinded
true
human_critique object · 5 fields
status
not_run
reviewer
null
signed_at
null
conflict_checked
false
commentary
null
stages array · 7 items
[0] object · 4 fields
key
target_materials
status
pending
reason
null
evidence
null
[1] object · 4 fields
key
independent_readings
status
blocked
reason
The independent readings are incomplete or disagree; the source evidence must resolve the difference.
evidence object · 1 field
provider_errors array · 0 items
[2] object · 4 fields
key
source_resolution
status
pending
reason
null
evidence
null
[3] object · 4 fields
key
protocol_reconstruction
status
pending
reason
null
evidence
null
[4] object · 4 fields
key
control_execution
status
pending
reason
null
evidence
null
[5] object · 4 fields
key
control_comparison
status
pending
reason
null
evidence
null
[6] object · 4 fields
key
publication
status
pending
reason
null
evidence
null
gaps array · 2 items
[0]
review.human_critique
[1]
review.machine_critique.blocked
execution object · 5 fields
state
absent
status
not_run
mode
null
runs array · 0 items
gaps array · 1 item
[0]
execution.not_run
provenance object · 7 fields
entities array · 1 item
[0] object · 3 fields
id
package:a94bd79521587ecd419c41ef62d31d37e481058471cbbe303177b8ba842f4598
type
sep_package
label
SEP v1 package for pmid:39751894
activities array · 1 item
[0] object · 4 fields
id
activity:conversion:pmid:39751894
type
conversion
used array · 1 item
[0]
package:a94bd79521587ecd419c41ef62d31d37e481058471cbbe303177b8ba842f4598
agent
agent:corpus-assay-engine
agents array · 3 items
[0] object · 3 fields
id
agent:minimax
type
model
label
minimax
[1] object · 3 fields
id
agent:minimax_alt
type
model
label
minimax_alt
[2] object · 3 fields
id
agent:corpus-assay-engine
type
software
label
Corpus assay engine
source_run_id
run-20261023T122449232913
dsl_catalogue_fingerprint
343fb30756ba6ec3
capability_table_fingerprint
2cb3e42f047d2ecf
snapshot_id
ba34b49490d9bfaf
lineage object · 4 fields
parent_id
pmid:39751894
parent_hash
sha256:76e1e916099b32ef94c4bcac886994e1cbcad605fcfca561b20d4ad009cac3bb
fork_of
null
gaps array · 13 items
[0]
abstract
[1]
asset:source:pmid:39751894 not verified
[2]
authors
[3]
capability
[4]
corpus_record_absent
[5]
execution.not_run
[6]
method
[7]
review.human_critique
[8]
review.machine_critique.blocked
[9]
step:obtain_source_data blocked on data:not_downloaded
[10]
step:run_analysis blocked on no owned computational capability is bound to this experiment
[11]
step:run_analysis input 'materials:the source data behind the published result in pmid:39751894' does not resolve to a declared asset
[12]
targets
Complete file
{"sci_version": "1.0", "schema": "https://corpus.bntrg.co.uk/sci/1.0/sci.schema.json", "id": "pmid:39751894", "kind": "science-record", "revision": 2, "content_hash": "sha256:3f4ec524d9d46a571f9ab71ab55a859d9b58b23f6c9759ec51aa132e025eace9", "created_at": "2026-11-01T10:25:48Z", "updated_at": "2026-11-01T14:01:32Z", "generator": {"name": "corpus-assay-engine", "converter": "sep_to_sci_v1", "source_package_schema": "urn:bntrg:sep:1.0.0"}, "paper": {"state": "partial", "title": "The correlation between LAG-3 expression and the efficacy of chemoimmunotherapy in advanced biliary tract cancer.", "doi": "10.1007/s00262-024-03878-0", "pmid": "39751894", "authors": null, "journal": "Cancer immunology, immunotherapy : CII", "year": 2025, "abstract": null, "claims": [{"id": "claim-1", "statement": "the headline numerical result the paper states for its main finding", "kind": "quantitative", "state": "complete", "target": {"value": 70.6, "unit": "percent", "tolerance": null, "source": "chars 1132-1275 of source sha256 c2cc7c034d43a161cbee6bf48b1df2ed9484287c0028b97b855f75c3c6d71774"}, "evidence": [{"asset": "source:pmid:39751894", "locator": "chars 1132-1275 of source sha256 c2cc7c034d43a161cbee6bf48b1df2ed9484287c0028b97b855f75c3c6d71774", "quote": "The objective response rate (ORR) was significantly higher in LAG-3-positive tumors than in LAG-3-negative tumors (70.6% vs. 33.3%, P = 0.029)."}]}], "gaps": ["abstract", "authors"]}, "experiment": {"state": "partial", "objective": "the headline numerical result the paper states for its main finding", "steps": [{"id": "read_published_estimate", "order": 1, "name": "Read the published estimate and its interval from the source", "kind": "other", "state": "complete", "blocked_on": null, "description": "The number a replication must land on, and the sentence it came from.", "duration_hours": null, "parameters": {}, "inputs": ["source:pmid:39751894"], "outputs": ["the published estimate, its unit and its interval"], "instruments": [], "reagents": []}, {"id": "obtain_source_data", "order": 2, "name": "Obtain the source data behind the published result", "kind": "data-preparation", "state": "blocked", "blocked_on": "data:not_downloaded", "description": "The published result cannot be recomputed without the data the paper analysed.", "duration_hours": null, "parameters": {}, "inputs": [], "outputs": ["the source data with its provenance"], "instruments": [], "reagents": []}, {"id": "run_analysis", "order": 3, "name": "Run the analysis programme", "kind": "analysis", "state": "blocked", "blocked_on": "no owned computational capability is bound to this experiment", "description": "Re-run the paper's analysis on the source data and produce the registered result. | SEP input not carried into the asset list: materials:the source data behind the published result in pmid:39751894", "duration_hours": null, "parameters": {}, "inputs": [], "outputs": ["the registered result"], "instruments": [], "reagents": []}], "materials": [], "instruments": [], "reagents": [], "conditions": {}, "gaps": ["step:obtain_source_data blocked on data:not_downloaded", "step:run_analysis blocked on no owned computational capability is bound to this experiment", "step:run_analysis input 'materials:the source data behind the published result in pmid:39751894' does not resolve to a declared asset"]}, "data": {"state": "partial", "assets": [{"id": "source:pmid:39751894", "role": "manuscript", "format": "xml", "media_type": "application/xml", "uri": "https://doi.org/10.1007/s00262-024-03878-0", "sha256": "sha256:c2cc7c034d43a161cbee6bf48b1df2ed9484287c0028b97b855f75c3c6d71774", "bytes": null, "access": "open", "state": "resolved", "reader": null, "reader_status": "reader_required", "identifier": "10.1007/s00262-024-03878-0", "version": null, "note": "Source read by the package builder: full_text.", "structure": {"access_state": "full_text"}}, {"id": "asset:table:pmid:39751894:1", "role": "table", "format": "jats-table", "media_type": "application/vnd.jats.table+json", "uri": null, "sha256": "sha256:effbc6714246de9e2ed13d14ecf64d0e237c36acd6b6b2eb601827dd9cb20893", "bytes": 1043, "access": "open", "state": "verified", "reader": "read_table", "reader_status": "available", "identifier": "section[10]/table-wrap[1]#Tab1", "version": null, "note": "Demographic difference between LAG-3-positive and LAG-3-negative subgroup", "structure": {"pmcid": "PMC11699023", "section_index": 10, "section_title": "Patient characteristics", "row_count": 20, "column_count": 5}, "table": {"label": "Table 1", "caption": "Demographic difference between LAG-3-positive and LAG-3-negative subgroup", "rows": [["Characteristic", "All (N = 44)", "LAG-3-positive (N = 17)", "LAG-3-negative (N = 27)", "P value"], ["Age"], ["Median (range), year", "67 (30–80)", "67 (30–80)", "68(35–80)", "0.407"], ["Sex (%)"], ["Male", "20 (45)", "8 (47)", "12 (44)", "> 0.99"], ["Female", "24 (55)", "9 (53)", "15 (56)"], ["Stage (%)"], ["II", "1 (2)", "0 (0)", "1 (4)", "NA"], ["III", "2 (5)", "0 (0)", "2 (7)"], ["IIIB", "4 (9)", "2 (12)", "2 (7)"], ["IVA", "7 (16)", "3 (18)", "4 (15)"], ["IVB", "30 (68)", "12 (70)", "18 (67)"], ["Primary tumor site (%)"], ["Intrahepatic bile duct", "26 (59)", "9 (53)", "17 (63)", "NA"], ["Extrahepatic bile duct", "11 (25)", "5 (29)", "6 (22)"], ["Gallbladder", "5 (11)", "1 (6)", "4 (15)"], ["Ampulla of vater", "2 (5)", "2 (12)", "0 (0)"], ["PD-L1 expression (%)"], ["CPS ≥ 1", "18 (41)", "14 (82)", "4 (15)", "< 0.001"], ["CPS < 1", "26 (59)", "3 (18)", "23 (85)"]], "row_count": 20, "column_count": 5, "numeric_cells": 50, "header_rows": 1, "locator": "section[10]/table-wrap[1]#Tab1"}}, {"id": "asset:table:pmid:39751894:2", "role": "table", "format": "jats-table", "media_type": "application/vnd.jats.table+json", "uri": null, "sha256": "sha256:fb8d2de8e853ca70f330eff0ba3e6f3aa90c0bef0fecf58f1108458d72f61791", "bytes": 492, "access": "open", "state": "verified", "reader": "read_table", "reader_status": "available", "identifier": "section[10]/table-wrap[2]#Tab2", "version": null, "note": "Response rate in this study", "structure": {"pmcid": "PMC11699023", "section_index": 10, "section_title": "Patient characteristics", "row_count": 9, "column_count": 2}, "table": {"label": "Table 2", "caption": "Response rate in this study", "rows": [["Best overall response", "N = 44 (%)"], ["Complete response", "0 (0)"], ["Partial response", "21 (47.7)"], ["Stable disease", "4 (9.1)"], ["Stable disease ≥ 12 weeks", "13 (29.5)"], ["Progressive disease", "5 (11.4)"], ["Not evaluated", "1 (2.3)"], ["Objective response", "21 (47.4)"], ["Long-term disease control", "34 (77.3)"]], "row_count": 9, "column_count": 2, "numeric_cells": 10, "header_rows": 1, "locator": "section[10]/table-wrap[2]#Tab2"}}], "gaps": ["asset:source:pmid:39751894 not verified"]}, "analysis": {"state": "absent", "methods": [], "targets": [], "gaps": ["method", "targets"]}, "capability": {"state": "absent", "requirements": [], "gaps": ["capability"]}, "readiness": {"state": "partial", "tier": null, "blocking_axis": null, "blocked_on": null, "axes": {}, "can_run": {"dsl_operations": [], "assets": ["source:pmid:39751894", "asset:table:pmid:39751894:1", "asset:table:pmid:39751894:2"], "steps": ["read_published_estimate"]}, "must_build": {"dsl_operations": [], "converters": [], "readers": ["xml"], "capabilities": [], "data_gaps": ["source:pmid:39751894"]}, "gaps": ["corpus_record_absent"]}, "review": {"state": "partial", "machine_critique": {"status": "blocked", "providers": [{"provider": "minimax", "model": "MiniMax-M3.1-Flash", "prompt_version": "full-text-reading-v1", "prompt_hash": "637d93870f423ad621f21057f8469d3ac69911136bc30089459152336b7c4520", "source_hash": "c2cc7c034d43a161cbee6bf48b1df2ed9484287c0028b97b855f75c3c6d71774", "raw_response_sha256": "sha256:2cb5d11e2729bb16dcac93ba5ac55da949c184fbf4bd17f681df4cab54cc776c", "raw_response_chars": 2471}, {"provider": "minimax_alt", "model": "MiniMax-M3", "prompt_version": "full-text-reading-v1", "prompt_hash": "3eeb2a7da4363c87b0de6dbea1909601a20252d9a4cd48dbe9f84e8c3564a799", "source_hash": "c2cc7c034d43a161cbee6bf48b1df2ed9484287c0028b97b855f75c3c6d71774", "raw_response_sha256": "sha256:12979860c58f21e78c7bfb6487cb9c4d74a5d96fc0371c99a2ad7a0e12398f46", "raw_response_chars": 34464}], "target_providers": [{"provider": "minimax", "model": "MiniMax-M3.1-Flash", "prompt_version": "replication-target-v2", "prompt_hash": "a54f7c24df0f409c0799bd6d6b9d26c6e69e94c2c0bf387788ab7f6cac589f94", "source_hash": "c2cc7c034d43a161cbee6bf48b1df2ed9484287c0028b97b855f75c3c6d71774", "raw_response": "{\"parent_value\":70.6,\"unit\":\"%\",\"evidence\":\"The objective response rate (ORR) was significantly higher in LAG-3-positive tumors than in LAG-3-negative tumors (70.6% vs. 33.3%, P = 0.029).\",\"target_result\":\"The objective response rate was 70.6% in LAG-3-positive tumors, compared with 33.3% in LAG-3-negative tumors.\",\"number_stated\":true}", "reading": {"parent_value": 70.6, "unit": "%", "evidence": "The objective response rate (ORR) was significantly higher in LAG-3-positive tumors than in LAG-3-negative tumors (70.6% vs. 33.3%, P = 0.029).", "target_result": "The objective response rate was 70.6% in LAG-3-positive tumors, compared with 33.3% in LAG-3-negative tumors.", "number_stated": true, "source_locator": "chars 1132-1275 of source sha256 c2cc7c034d43a161cbee6bf48b1df2ed9484287c0028b97b855f75c3c6d71774"}, "recorded_at": "2026-10-31T15:26:22.006161+00:00"}, {"provider": "minimax_alt", "model": "MiniMax-M3", "prompt_version": "replication-target-v2", "prompt_hash": "ff02a4c17d4788b9600fbae36de818f0a8154a1312c26fbecb23b8334cb09519", "source_hash": "c2cc7c034d43a161cbee6bf48b1df2ed9484287c0028b97b855f75c3c6d71774", "raw_response": "<think>We need answer JSON only. Need interpret request: single numerical result replication registered target main finding. Need headline number only, paper stated, unit printed. Target broad \"headline numerical result paper states for main finding\". Need determine likely main headline number from abstract. Could be ORR 70.6% vs 33.3%, P=.029. \"headline numerical result\" likely 70.6%? Main finding LAG-3 positivity predicts efficacy, objective response rate. Need exact contiguous quotation contains number, whole clause for attribution. Need parent_value number likely 70.6, unit \"%\". Evidence exact sentence: \"The objective response rate (ORR) was significantly higher in LAG-3-positive tumors than in LAG-3-negative tumors (70.6% vs. 33.3%, P = 0.029).\" That contains both. But asks \"single numerical result\" headline number only, value paper states for registered target. They expect one number. Could headline result be 38.6% LAG-3 positivity? Yet main finding as efficacy likely ORR 70.6 vs 33.3. Registered target intentionally generic. Need output one number and unit. Evidence must quote whole clause. target_result likely \"70.6%\" maybe. number_stated true. parent_value 70.6. Need ensure exact quotation and no shortening. \"The objective response rate (ORR) was significantly higher...\" Whole clause/sentence. Evidence contains multiple numerical values, but headline number only in parent_value. Is that okay? They insist evidence exact contiguous quote contains number. likely.\n\nCould potentially headline numerical result be deeper therapeutic response, 20.1%, 38.6%, 57.6%. But main headline abstract results usually first ORR. Let's parse wording: \"find the single numerical result that a replication of the registered target has to reproduce. REGISTERED TARGET: the headline numerical result the paper states for its main finding.\" This likely benchmark where target description vague and extract headline. Main finding could be \"LAG-3 expression may serve as biomarker\", headline numerical result ORR significantly higher: 70.6% vs 33.3%. Single result perhaps 70.6% (the positive group's ORR), comparison 33.3. Need perhaps evidence entire clause \"The objective response rate (ORR) was significantly higher in LAG-3-positive tumors than in LAG-3-negative tumors (70.6% vs. 33.3%, P = 0.029).\" Good.\n\nCould unit be \"%\" exactly printed. parent_value 70.6. target_result maybe \"The objective response rate was 70.6% in LAG-3-positive tumors.\" But should only headline number? They request target_result perhaps state result. We can put \"70.6%\" only. Need valid JSON escaping? Evidence exact Unicode en dash etc not issue. We must not invent source. Use exact source. Ensure exact quotation punctuation. Sentence from source exactly. Let's deliver JSON.</think>\n\n{\"parent_value\":70.6,\"unit\":\"%\",\"evidence\":\"The objective response rate (ORR) was significantly higher in LAG-3-positive tumors than in LAG-3-negative tumors (70.6% vs. 33.3%, P = 0.029).\",\"target_result\":\"70.6%\",\"number_stated\":true}", "reading": {"parent_value": 70.6, "unit": "%", "evidence": "The objective response rate (ORR) was significantly higher in LAG-3-positive tumors than in LAG-3-negative tumors (70.6% vs. 33.3%, P = 0.029).", "target_result": "70.6%", "number_stated": true, "source_locator": "chars 1132-1275 of source sha256 c2cc7c034d43a161cbee6bf48b1df2ed9484287c0028b97b855f75c3c6d71774"}, "recorded_at": "2026-10-31T15:26:24.676693+00:00"}], "agreement": false, "disagreements": {"work_type": {"minimax": "analysis_only_for_target", "minimax_alt": "analysis_plus_physical_validation", "decisive": true}, "physical_methods": {"minimax": [], "minimax_alt": ["Immunohistochemical staining for PD-L1 and LAG-3", "Digital spatial profiling in selected regions of interest"], "decisive": false}}, "agreement_basis": {"policy": "decisive_fields", "decisive_fields": ["work_type", "number_stated", "parent_value", "unit"]}, "blinded": true}, "human_critique": {"status": "not_run", "reviewer": null, "signed_at": null, "conflict_checked": false, "commentary": null}, "stages": [{"key": "target_materials", "status": "pending", "reason": null, "evidence": null}, {"key": "independent_readings", "status": "blocked", "reason": "The independent readings are incomplete or disagree; the source evidence must resolve the difference.", "evidence": {"provider_errors": []}}, {"key": "source_resolution", "status": "pending", "reason": null, "evidence": null}, {"key": "protocol_reconstruction", "status": "pending", "reason": null, "evidence": null}, {"key": "control_execution", "status": "pending", "reason": null, "evidence": null}, {"key": "control_comparison", "status": "pending", "reason": null, "evidence": null}, {"key": "publication", "status": "pending", "reason": null, "evidence": null}], "gaps": ["review.human_critique", "review.machine_critique.blocked"]}, "execution": {"state": "absent", "status": "not_run", "mode": null, "runs": [], "gaps": ["execution.not_run"]}, "provenance": {"entities": [{"id": "package:a94bd79521587ecd419c41ef62d31d37e481058471cbbe303177b8ba842f4598", "type": "sep_package", "label": "SEP v1 package for pmid:39751894"}], "activities": [{"id": "activity:conversion:pmid:39751894", "type": "conversion", "used": ["package:a94bd79521587ecd419c41ef62d31d37e481058471cbbe303177b8ba842f4598"], "agent": "agent:corpus-assay-engine"}], "agents": [{"id": "agent:minimax", "type": "model", "label": "minimax"}, {"id": "agent:minimax_alt", "type": "model", "label": "minimax_alt"}, {"id": "agent:corpus-assay-engine", "type": "software", "label": "Corpus assay engine"}], "source_run_id": "run-20261023T122449232913", "dsl_catalogue_fingerprint": "343fb30756ba6ec3", "capability_table_fingerprint": "2cb3e42f047d2ecf", "snapshot_id": "ba34b49490d9bfaf"}, "lineage": {"parent_id": "pmid:39751894", "parent_hash": "sha256:76e1e916099b32ef94c4bcac886994e1cbcad605fcfca561b20d4ad009cac3bb", "fork_of": null, "generation": 2}, "gaps": ["abstract", "asset:source:pmid:39751894 not verified", "authors", "capability", "corpus_record_absent", "execution.not_run", "method", "review.human_critique", "review.machine_critique.blocked", "step:obtain_source_data blocked on data:not_downloaded", "step:run_analysis blocked on no owned computational capability is bound to this experiment", "step:run_analysis input 'materials:the source data behind the published result in pmid:39751894' does not resolve to a declared asset", "targets"]}